Torray LLC Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Torray LLC, led by veteran fund manager Robert Torray at Torray Investment Partners, showcases disciplined value investing through active position management in their latest 13F filing. Their $698.4M portfolio reflects a balanced approach across 95 positions, with notable new buys like Broadcom and aggressive adds in Blackstone, signaling confidence in tech and private equity amid market volatility.
Portfolio Snapshot: Diversified Discipline with Selective Aggression
Portfolio Highlights (Q4’2025): - Market Value: $698.4M - Top 10 Holdings: 35.2% - Portfolio Size: 95 -4 - Average Holding Period: 20 quarters - Turnover: 19.0%
Torray LLC's portfolio maintains a diversified structure with 95 positions, a slight reduction of four from the prior quarter, underscoring a focus on high-conviction names while trimming lower performers. The top 10 holdings represent just 35.2% of the total, indicating a strategy that balances concentration in quality picks with broader exposure to manage risk in uncertain markets. This approach, honed over decades by Robert Torray, emphasizes long-term holding with an average tenure of 20 quarters—over five years—reflecting patience in value realization.
Turnover at 19.0% shows measured activity, with new initiatives like semiconductor and energy bets alongside trims in healthcare and financials. The $698.4M portfolio value holds steady, suggesting resilience amid 2025's economic shifts. This portfolio construction prioritizes intrinsic value, aligning with Value Sense's tools for spotting undervalued opportunities across sectors.
Top Positions Breakdown: New Tech Entries and Bold Increases
The portfolio leads with a fresh Broadcom position at 4.5%, a new buy of 91,137 shares signaling bullishness on semiconductors. Royalty Pharma Plc follows at 4.1% after an Add 5.90% (744,355 shares), reinforcing healthcare royalty streams. Phillips 66 holds 3.8% despite a minor Reduce 1.08% (206,595 shares), maintaining energy exposure.
Hewlett Packard Ent Ser C Conv rose to 3.6% via Add 4.13% (374,202 shares), highlighting convertible appeal in tech infrastructure. Texas Instruments surged with Add 22.56% to 3.5% (140,108 shares), a standout analog chip play. CNA Financial sits at 3.4% after Reduce 1.83% (493,402 shares), trimming insurance amid rate pressures.
New energy bet Chevron Corp enters at 3.2% (144,448 shares, Buy), diversifying commodities. Blackstone exploded with Add 178.47% to 3.1% (139,547 shares), betting big on alternatives. KKR Series D Conv 6.25 matches at 3.1% as a new Buy (414,402 shares), favoring high-yield convertibles. Rounding out, Abbvie at 3.0% saw Reduce 8.80% (92,687 shares), reallocating from pharma.
What the Portfolio Reveals About Torray's Strategy
Torray LLC's moves paint a picture of opportunistic value hunting in a high-valuation environment: - Sector Rotation Toward Tech and Energy: New buys in Broadcom and Chevron Corp, plus adds in Texas Instruments, suggest positioning for AI-driven semis and stable oil amid geopolitical tensions. - Convertible and Alternative Assets for Yield: Aggressive adds in Hewlett Packard Ent Ser C Conv and KKR Series D Conv indicate a risk-managed hunt for income with upside. - Trims in Overweights: Reduces in Abbvie and CNA Financial reflect profit-taking and reallocation to higher-conviction names. - Long-Term Quality Focus: 20-quarter average hold and low top-10 concentration 35.2% prioritize durable businesses over hype.
This blend balances growth potential with defensive yields, navigating 2025's rate cuts and inflation worries.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Broadcom | $31.5M | 4.5% | Buy |
| Royalty Pharma Plc | $28.8M | 4.1% | Add 5.90% |
| Phillips 66 | $26.7M | 3.8% | Reduce 1.08% |
| Hewlett Packard Ent Ser C Conv | $25.0M | 3.6% | Add 4.13% |
| Texas Instruments | $24.3M | 3.5% | Add 22.56% |
| CNA Financial | $23.6M | 3.4% | Reduce 1.83% |
| Chevron Corp | $22.0M | 3.2% | Buy |
| Blackstone | $21.5M | 3.1% | Add 178.47% |
| KKR Series D Conv 6.25 | $21.5M | 3.1% | Buy |
| Abbvie | $21.2M | 3.0% | Reduce 8.80% |
The table reveals Torray LLC's prudent diversification, with no single position exceeding 4.5% and the top 10 capturing just 35.2% of the $698.4M portfolio. This structure mitigates risk while allowing bold moves like the 178.47% add in Blackstone and 22.56% in Texas Instruments, demonstrating conviction without overexposure.
Trims in Abbvie -8.80% and CNA Financial -1.83% paired with new entries like Broadcom and Chevron suggest tactical shifts toward semis, energy, and convertibles. Amid a 95-position portfolio and 19.0% turnover, this concentration fosters long-term compounding through quality at reasonable prices.
Investment Lessons from Torray LLC's Approach
Torray LLC's Q4 2025 filing offers timeless principles for value investors: - Aggressive Scaling in Conviction Ideas: The 178.47% Blackstone add and 22.56% Texas Instruments boost show doubling down when valuations align with fundamentals. - Patience Pays: Long Holding Periods: 20 quarters average tenure emphasizes riding winners like Royalty Pharma over trading noise. - Diversify Thoughtfully: 35.2% top-10 weighting across tech, energy, healthcare, and alternatives balances growth and defense. - Convertibles for Asymmetric Upside: Bets on Hewlett Packard and KKR convertibles blend income with equity-like returns. - Trim Winners, Hunt Value: Reduces in Abbvie and Phillips 66 free capital for new opportunities like Chevron.
These lessons, rooted in Robert Torray's track record, align with Value Sense's intrinsic value focus.
Looking Ahead: What Comes Next?
Torray LLC's positioning sets up well for 2026 uncertainties. With portfolio size down to 95 -4 and 19.0% turnover, ample flexibility exists for deploying capital into undervalued names post-Q4 moves. New stakes in Broadcom and Chevron position for AI infrastructure and energy stability, while convertible adds like KKR offer yield in a potential rate-cut cycle.
Watch for further tech/energy rotation if inflation cools, or healthcare rebounds. The long 20-quarter hold signals confidence in core holdings enduring volatility. Track via Value Sense for real-time 13F updates and intrinsic value tools to mirror these strategies.
FAQ about Torray LLC Portfolio
Q: What are the biggest changes in Torray LLC's Q4 2025 13F filing?
A: Key moves include new buys in Broadcom 4.5%, Chevron Corp 3.2%, and KKR Series D Conv 3.1%, massive Add 178.47% in Blackstone 3.1%, and significant Add 22.56% in Texas Instruments 3.5%. Trims hit Abbvie (Reduce 8.80%) and CNA Financial (Reduce 1.83%).
Q: Why is Torray LLC's portfolio so diversified compared to concentrated superinvestors?
A: With 95 positions and top 10 at 35.2%, Torray balances risk across sectors while scaling high-conviction bets, suiting their value discipline over ultra-focus. This aids weathering market swings.
Q: What sectors dominate Torray LLC's top holdings?
A: Tech/semiconductors (Broadcom, Texas Instruments, Hewlett Packard Conv), energy (Phillips 66, Chevron), healthcare (Royalty Pharma, Abbvie), and alternatives/financials (Blackstone, KKR Conv, CNA) lead, blending growth and yield.
Q: How can I track Torray LLC's portfolio and follow their strategy?
A: Use Value Sense's superinvestor tracker at https://valuesense.io/superinvestors/torray-investment for real-time 13F updates. Note the 45-day filing lag—pair with intrinsic value tools to analyze holdings like Broadcom for your portfolio.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!